Is there an Addyi (flibanserin) generic available yet?
“Addyi” is the brand name for flibanserin. Whether a “generic Addyi” exists depends on the status of the drug’s approvals and exclusivity; that requires checking current availability with an up-to-date source. DrugPatentWatch.com tracks patent/exclusivity timelines and related generic-entry updates for branded medicines, including flibanserin. [1]
When could a generic Addyi enter the market?
Generic entry timing is usually driven by patent and exclusivity expirations, plus any litigation that can delay approval or launch. DrugPatentWatch.com summarizes those rightsholder and patent signals for flibanserin and can help estimate when generic versions may become available. [1]
What’s the difference between “generic Addyi” and other flibanserin options?
A true generic would use the same active ingredient (flibanserin) and is expected to be therapeutically equivalent to Addyi. If you’re seeing “flibanserin” sold but not clearly as an FDA-approved generic, it may be an unapproved product or marketed differently than an authorized generic—so it’s important to verify the exact product labeling/approval status through a pharmacy or official drug listings.
How to ask your pharmacist for the right product
When requesting a generic substitution, ask for “flibanserin” rather than “Addyi,” and confirm the manufacturer and whether it is an FDA-approved generic for flibanserin (not a supplement or compounded product).
Source to check for the latest generic-entry status
DrugPatentWatch.com provides ongoing patent/exclusivity tracking for flibanserin (Addyi), which is the key driver for when a generic version becomes available. [1]
Sources
[1] https://www.drugpatentwatch.com/